Open | $4.490 |
Close | $4.115 |
Volume / Avg. | 2.276M / 2.142M |
Day Range | 4.100 - 4.555 |
52 Wk Range | 1.300 - 5.220 |
Market Cap | $2.961B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | % |
Days to Cover | 4.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Summit Therapeutics (NASDAQ: SMMT) through any online brokerage.
Other companies in Summit Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and Arrowhead Pharma (NASDAQ:ARWR).
The latest price target for Summit Therapeutics (NASDAQ: SMMT) was reported by HC Wainwright & Co. on Wednesday, November 18, 2020. The analyst firm set a price target for 0.00 expecting SMMT to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Summit Therapeutics (NASDAQ: SMMT) is $4.22 last updated March 18, 2024 at 4:46 PM EDT.
There are no upcoming dividends for Summit Therapeutics.
Summit Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Summit Therapeutics.
Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.